scholarly article | Q13442814 |
P50 | author | Guillermo Gonzalez-Burgos | Q57032562 |
David A. Lewis | Q28112847 | ||
P2093 | author name string | Gwenn Hansen | |
Michael Flynn | |||
Robert Zaczek | |||
Brian Zambrowicz | |||
Ryan S Westphal | |||
Yuval Blat | |||
Hiroki Yoshino | |||
Takeaki Miyamae | |||
Donna Pedicord | |||
P2860 | cites work | Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. | Q51900322 |
Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. | Q52582276 | ||
Reporting ethical matters in the Journal of Physiology: standards and advice | Q58670204 | ||
CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons | Q60155175 | ||
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight | Q60690528 | ||
Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex | Q73144996 | ||
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 | ||
Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 | ||
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling | Q24658561 | ||
Prelimbic and infralimbic prefrontal cortex interact during fast network oscillations | Q27300868 | ||
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types | Q28262858 | ||
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids | Q28282550 | ||
Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus | Q28286042 | ||
Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons | Q28296327 | ||
Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus | Q28363366 | ||
ADP-ribosylation factor-like 3 is involved in kidney and photoreceptor development | Q28512728 | ||
Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3 | Q28573633 | ||
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system | Q28590486 | ||
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice | Q28591248 | ||
Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention | Q28591574 | ||
The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission | Q28594648 | ||
Cellular basis of working memory | Q29615398 | ||
Successful choice behavior is associated with distinct and coherent network states in anterior cingulate cortex | Q30483090 | ||
Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells | Q32066435 | ||
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex | Q33293523 | ||
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses | Q33814760 | ||
Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase | Q33816013 | ||
M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes | Q33904869 | ||
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus | Q33996513 | ||
Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex | Q34001324 | ||
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. | Q34025536 | ||
Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus | Q34044829 | ||
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls | Q34098167 | ||
Working Memory Performance Correlates with Prefrontal-Hippocampal Theta Interactions but not with Prefrontal Neuron Firing Rates. | Q34112993 | ||
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure | Q34233915 | ||
Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered | Q34365287 | ||
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia | Q34384480 | ||
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex | Q34536072 | ||
Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus. | Q34605733 | ||
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. | Q34684362 | ||
Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons | Q35000519 | ||
Diacylglycerol lipase-alpha and -beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms | Q35080503 | ||
Target-selective GABAergic control of entorhinal cortex output | Q35114673 | ||
Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress | Q35162864 | ||
Molecular composition of the endocannabinoid system at glutamatergic synapses. | Q35220762 | ||
Endocannabinoid signaling and long-term synaptic plasticity. | Q35679432 | ||
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons | Q36018163 | ||
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells | Q36431865 | ||
Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. | Q36693029 | ||
Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus | Q36827193 | ||
Cannabinoid sensitivity and synaptic properties of 2 GABAergic networks in the neocortex. | Q36876939 | ||
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus | Q36917918 | ||
Perisomatic inhibition. | Q36962678 | ||
Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex | Q36978617 | ||
GABA transporter GAT1 prevents spillover at proximal and distal GABA synapses onto primate prefrontal cortex neurons | Q37131875 | ||
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease | Q37262759 | ||
Comparing the prefrontal cortex of rats and primates: insights from electrophysiology | Q37346471 | ||
Endocannabinoid-mediated control of synaptic transmission | Q37363621 | ||
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling | Q37416400 | ||
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons | Q37444504 | ||
Establishing a physiological environment for visualized in vitro brain slice recordings by increasing oxygen supply and modifying aCSF content. | Q37518575 | ||
DAG Lipase Involvement in Depolarization-Induced Suppression of Inhibition: Does Endocannabinoid Biosynthesis Always Meet the Demand? | Q37788467 | ||
Supply and demand for endocannabinoids | Q37867227 | ||
Presynaptic specificity of endocannabinoid signaling in the hippocampus | Q39750122 | ||
Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism | Q39933219 | ||
Dynamics of population code for working memory in the prefrontal cortex | Q40558059 | ||
Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells | Q41808335 | ||
The endocannabinoid system controls key epileptogenic circuits in the hippocampus | Q42065383 | ||
Selective cholinergic modulation of cortical GABAergic cell subtypes | Q42444804 | ||
Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. | Q42528169 | ||
Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats | Q42618475 | ||
CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1. | Q42714536 | ||
Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning | Q43002082 | ||
Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus. | Q43158690 | ||
Self-modulation of neocortical pyramidal neurons by endocannabinoids | Q43241797 | ||
Flexible spike timing of layer 5 neurons during dynamic beta oscillation shifts in rat prefrontal cortex. | Q43276900 | ||
Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability | Q44437517 | ||
Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors | Q44553567 | ||
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. | Q44741537 | ||
Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. | Q44919566 | ||
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 | ||
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 | ||
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. | Q45937148 | ||
Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. | Q46055962 | ||
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes | Q46564021 | ||
Multiple mechanisms of endocannabinoid response initiation in hippocampus. | Q46738182 | ||
Endocannabinoids control the induction of cerebellar LTD. | Q46814707 | ||
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis | Q46934838 | ||
Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference | Q46947462 | ||
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex | Q46962183 | ||
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release | Q48094449 | ||
Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus | Q48171504 | ||
P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex. | Q48257507 | ||
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. | Q48291065 | ||
N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. | Q48399171 | ||
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. | Q48420895 | ||
Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice | Q48489226 | ||
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. | Q48556515 | ||
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis | Q48655780 | ||
Pharmacological activation of kainate receptors drives endocannabinoid mobilization | Q48899592 | ||
P433 | issue | Pt 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endocannabinoids | Q10483908 |
P304 | page(s) | 4857-4884 | |
P577 | publication date | 2011-08-01 | |
P1433 | published in | Journal of Physiology | Q7743612 |
P1476 | title | Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex | |
P478 | volume | 589 |
Q39191943 | 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. |
Q38821053 | 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex |
Q48626643 | Activation of type-1 cannabinoid receptor shifts the balance between excitation and inhibition towards excitation in layer II/III pyramidal neurons of the rat prelimbic cortex |
Q46377349 | Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol |
Q38026790 | Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. |
Q37128137 | CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses |
Q36797226 | CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling |
Q36904318 | Cannabinoid modulation of backpropagating action potential-induced calcium transients in layer 2/3 pyramidal neurons |
Q64285404 | Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells |
Q34156640 | Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids |
Q42606859 | Cholinergic modulation of neuronal excitability and recurrent excitation-inhibition in prefrontal cortex circuits: implications for gamma oscillations |
Q26824698 | Control of synaptic function by endocannabinoid-mediated retrograde signaling |
Q41544348 | Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase |
Q35672654 | Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice |
Q92281820 | Diacylglycerol Lipase-Alpha Regulates Hippocampal-Dependent Learning and Memory Processes in Mice |
Q36830115 | Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain. |
Q37027072 | Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons |
Q36831875 | Endocannabinoid metabolism in the prefrontal cortex in schizophrenia |
Q34304094 | Endocannabinoid signaling and synaptic function |
Q30843851 | Endocannabinoid signalling modulates susceptibility to traumatic stress exposure |
Q36389209 | Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. |
Q36332761 | Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex |
Q57055931 | Endocannabinoids and related -acylethanolamines: biological activities and metabolism |
Q37979989 | Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know |
Q43832701 | Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex |
Q33624983 | Endogenous cannabinoid signaling at inhibitory interneurons. |
Q30671214 | Functional Maturation of GABA Synapses During Postnatal Development of the Monkey Dorsolateral Prefrontal Cortex |
Q38056394 | Functional diversity on synaptic plasticity mediated by endocannabinoids |
Q50200300 | Functional relevance of endocannabinoid-dependent synaptic plasticity in the CNS. |
Q38593120 | Genetic Manipulation of the Endocannabinoid System |
Q34718086 | Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation |
Q37691232 | Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. |
Q35693020 | Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. |
Q35053193 | Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies |
Q45069048 | Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model |
Q48836921 | Key questions of endocannabinoid signalling in the CNS: which, where and when? |
Q37969448 | Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. |
Q26998964 | Monoacylglycerol lipase - a target for drug development? |
Q34270199 | Multiple functions of endocannabinoid signaling in the brain. |
Q38253634 | Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortex |
Q41497658 | Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum |
Q35325228 | Nuclear diacylglycerol lipase-α in rat brain cortical neurons: evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity. |
Q45838779 | Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1. |
Q86425659 | Preformed vs. on-demand: molecular economics of endocannabinoid signalling |
Q38732779 | Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis. |
Q39381131 | Synaptic functions of endocannabinoid signaling in health and disease |
Q38659944 | The Endocannabinoid Signaling System in the CNS: A Primer. |
Q35034305 | The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium |
Q26862444 | Why do cannabinoid receptors have more than one endogenous ligand? |
Search more.